Q-Pharm SRL
Q-Pharm reported total assets of 145,692 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jul 2026).
The score of Q-Pharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +194 % Total assets +184 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Q-Pharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jul 2026
- Year ended 31 Dec 2024filed on 28 Jul 2025
- Year ended 31 Dec 2022filed on 30 Aug 2023
Q-Pharm's financial analysis
- Solvency54.9%sector median: 50.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Q-Pharm
Q-Pharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0783.650.231
- VAT number
- BE0783650231
- Peppol
- Registered · 0208:0783650231 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Mar 2022
- Registered office
- 1190 Forest
- Latest accounts
- 2025 · filed on 27 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Q-Pharm (SRL) has been based in Forest since 2022, active in: business and other management consultancy activities. For 2025, it reports a net profit of 39,508 € and equity of 80,000 €; its revenue is not published. Its solvency stands at 54.9%, above the median of its sector (50.7%).
Companies similar to Q-Pharm
Companies in the same business, of comparable size and area, outside its group.
- Octopod Business and other management consultancy activities Oostkamp · balance sheet 145,669 €
- Millenium Business Consult Business and other management consultancy activities Lasne · balance sheet 145,782 €
- JOCHIEF Management Business and other management consultancy activities Binche · balance sheet 145,595 €
- Philae Consulting Business and other management consultancy activities Westerlo · balance sheet 145,789 €
- Animus Consulting Business and other management consultancy activities Huldenberg · balance sheet 145,819 €
- Serliv Business and other management consultancy activities Boutersem · balance sheet 145,873 €
- Coleo Business and other management consultancy activities Beyne-Heusay · balance sheet 145,479 €
- Warranty, Advice and Consulting Business and other management consultancy activities Geel · balance sheet 145,937 €
Frequently asked questions about Q-Pharm
What is the revenue of Q-Pharm?
Q-Pharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Q-Pharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0783650231 for Q-Pharm, if the company is VAT-registered. Its company number (CBE) is 0783.650.231.
Where is the registered office of Q-Pharm?
According to the CBE register, the registered office of Q-Pharm is in 1190 Forest.
What is the equity of Q-Pharm?
At the close of the 2025 financial year, the equity of Q-Pharm amounts to 80,000 €, a solvency of 54.9% of total assets.
Who manages Q-Pharm?
The register lists 1 active mandates at Q-Pharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Q-Pharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →